A New York City-based health organization is proposing that restaurants and packaged food manufacturers lower sodium levels by 25% over five years to greatly reduce preventable health risks.
No Comments »
Filed under: General Health News
A year after the FDA issued mortality warnings about antipsychotic drugs in the elderly, nearly 30% of nursing home residents received the medications (MedPage Today) — and a third of those had had no indication for the drugs, a study revealed.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — A cardiovascular advisory panel has unanimously agreed that the FDA should not expand the indications for the beta blocker nebivolol (Bystolic) to include treatment of heart failure in older patients.
No Comments »
Filed under: Pharmacy News
WASHINGTON (MedPage Today) — The FDA has announced a consent decree with medical device manufacturer Sybaritic that requires the company to cease production and distribution of laser surgery, dermatological, and spa devices until it complies with the agency’s quality standards.
No Comments »
Filed under: Pharmacy News
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 2, a Phase IIa clinical program evaluating the company’s investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non [...]
No Comments »
Filed under: Pharmacy News
Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company’s increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference [...]
No Comments »
Filed under: Pharmacy News
Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, if Pfizer/Medivation’s Dimebon shows efficacy in two ongoing clinical trials in moderate to severe Alzheimer’s disease that is equivalent to the impressive clinical trial data it has already shown to date in mild to moderate patients, these [...]
No Comments »
Filed under: Pharmacy News
A leading clinical research center in Salt Lake City has joined an international trial program to test an experimental new drug designed to treat painful menstrual cramps, or dysmenorrhea, a condition that affects between 45 and 90 percent of women of childbearing age in the United States. Although not life threatening, dysmenorrhea can be debilitating [...]
No Comments »
Filed under: Pharmacy News
CEL-SCI Corporation, a late-stage oncology company and a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases, announced today it has completed the validation of all critical utilities and manufacturing equipment at its GMP manufacturing facility in Maryland.
No Comments »
Filed under: Pharmacy News
NicOx S.A. today announced that NicOx and TOPIGEN Pharmaceuticals Inc. have mutually terminated their collaboration for TPI 1020. This decision was made as a result of the acquisition of TOPIGEN by Pharmaxis announced yesterday.
No Comments »
Filed under: Pharmacy News
